Table 1.
A summary of the postinjection endophthalmitis cases at Oslo University Hospital in the pre‐pandemic and pandemic period.
|
Pre‐pandemic period n = 68 150 |
Pandemic period n = 25 904 |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Case | Age | Sex | Diagnosis | Drug | Pathogen | Case | Age | Sex | Diagnosis | Drug | Pathogen |
| 1 | 76 | M | nAMD | R | Unknown | 1 | 88 | F | nAMD | A | S. aureus |
| 2 | 68 | F | nAMD | B | S. epidermidis | 2 | 91 | F | nAMD | A | S. epidermidis |
| 3 | 65 | M | RVO | A | S. epidermidis | 3 | 78 | F | nAMD | B | S. epidermidis |
| 4 | 82 | M | nAMD | A | S. epidermidis | 4 | 78 | F | nAMD | A | S. epidermidis |
| 5 | 68 | F | nAMD | A | Unknown | 5 | 85 | F | nAMD | A | S. aureus |
| 6 | 89 | F | RVO | A | S. gordonii | ||||||
| 7 | 82 | F | RVO | B | Unknown | ||||||
M, male; F, female; nAMD, neovascular age‐related macular degeneration; RVO, retinal vein occlusion; S. epidermidis, Staphylococcus epidermidis; S. aureus, Staphylococcus aureus, S. gordonii, Streptococcus gordonii.